Key result
CRT is linked to improved regional myocardial perfusion in ~92% of patients within two months.
Why the study?
Does CRT improve regional wall motion, perfusion, and reverse remodelling in heart failure patients?
Observational (n=36)
Does CRT improve regional wall motion, perfusion, and reverse remodelling in heart failure patients?
The main effects of CRT on regional myocardial perfusion and wall motion in heart failure patients are obtained within 2 months, with end diastolic volume, perfusion defects, and diabetes being independent predictors of survival.
Answers are grounded in this paper and cite their sources.
Small observational series should not guide CRT selection or monitoring; leaves open whether G-SPECT perfusion predicts reverse remodelling.
In patients treated with CRT no data relative to the relationship between regional wall motion and perfusion and reverse remodelling of the left ventricle at short and medium term followup were available. To this aim, 36 heart failure patients were studied by G-SPECT before (T0), within 2 months (T1) and 6 months (T2) after CRT. A clinical followup was completed for 36 months. In 30/36 patients there was an improvement of NYHA Class at T1 that persisted at T2. G-SPECT showed significant improvement of perfusion at T1 in 92% of patients without further changes at T2. A reduction of LV volumes, an increase of EF and an improvement of regional wall motion and thickening were observed at T1 versus baseline, with only minor changes at T2. Moreover, baseline extension of perfusion defects was scarcely correlated with improvement after CRT. Finally, end diastolic volume, perfusion defect and diabetes mellitus were independent predictors of survival. The main effects of CRT on regional myocardial perfusion and wall motion are obtained within 2 months. Volume overload modulates recovery of ventricular function independently of reperfusion and, with extension of perfusion abnormalities and diabetes were independent predictors of survival during followup.
No takes yet. Share an insight, caveat, or question.
Gimelli et al. (2010) conducted an observational in Heart failure (n=36). Cardiac Resynchronization Therapy (CRT) vs. Baseline was evaluated on Improvement of perfusion at 2 months. Cardiac resynchronization therapy improved regional myocardial perfusion in 92% of heart failure patients and functional class in 83% within 2 months, with no further major changes at 6 months.
Synapse has enriched 10 related papers. Consider them for comparative context: